$13MSeed, 26 January 2026
Launched from stealth with $13M seed to take its lead immune cell targeting biologic through IND-enabling studies.
- Amount
- $13M
- Stage
- Seed
- Announced
- 26 January 2026
- Lead
- K2 Bio Partners
- Other investors
- Shanghai Healthcare Angel Capital, Elikon Venture
- Use of funds
- Launched from stealth with $13M seed to take its lead immune cell targeting biologic through IND-enabling studies.
- Checked
- Announced by the company
- Sources
- Fortitude Biomedicines Launches With $13 Million Seed Funding businesswire.com
Fortitude Biomedicines Launches With $13 Million Seed Funding pulse2.com